StockWatch
·

BLUE STAR LTD.

BSE: 500067

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
2.8K
-14.1%+19.8%
Expenditure
2.7K
-13.5%+22.6%
Net Profit
38.24
-44.9%-45.3%
OPM %
4.24%
-0.04pp-1.73pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.001.1K2.2K3.3K4.4KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Blue Star Q2 FY27: PAT +25% YoY but Flat Ex-Exceptional as RAC Margins Stay Squeezed

room air conditioners · margin compression · commodity cost inflation

ResultsQ2 FY2729 Oct 20263 minConsumer & Retail

Unitary Margins at the Crossroads — Data Center MEP Holding Growth

HVAC margins · unitary compression · data center MEP

Result previewQ2 FY2723 Oct 20263 minConsumer & Retail

Growth masks margin collapse; recovery credibility tested

margin compression · cost pass-on · RAC

Result verdictFollow-upQ1 FY2716 Aug 20266 minConsumer & Retail
Latest
Board Meeting29 Oct, 4:15 pm

Blue Star Q2: One-Off Gain Lifts Consolidated PAT 25%, Standalone Profit Halves YoY

Blue Star's consolidated Q2 FY27 revenue rose 21.0% YoY to ₹2,930.95 Cr (down 13.2% QoQ, tracking the Unitary segment's seasonal slowdown after the summer peak), and reported PAT rose 25.4% YoY to ₹123.91 Cr. That headline is flattered by a ₹23.02 Cr exceptional gain the Group booked on the completed sale of subsidiary Blue Star Engineering & Electronics' Medtech business; stripping it out (at the quarter's ~21% effective tax rate), adjusted PAT grew only about 7% YoY to roughly ₹106 Cr — well behind revenue growth and the clearer signal that underlying profitability is still under pressure. The compression sits almost entirely in the Unitary Products segment (room ACs and commercial refrigeration): EBIT margin was just 2.31% (₹20.74 Cr on ₹897.66 Cr revenue) against the >6.5% FY27 target (aspiring 7-7.5%) management set out on the August 13, 2026 concall, barely improved from Q1 FY27's 2.94% — exactly the input-cost and pricing pressure the segment has been flagged for since Q1. The Electro-Mechanical Projects & Commercial AC segment is the quarter's carrier: margin 6.88%, inside the guided 6.5-7% band, on revenue up 16.3% YoY to ₹1,935.99 Cr. Blended consolidated operating margin came to 6.91%, down from 7.57% a year ago though up sequentially from Q1's 5.18%. The parent-only (standalone) numbers tell a materially different story than consolidated and are worth flagging explicitly: standalone PAT fell 45.3% YoY to ₹38.24 Cr (from ₹69.91 Cr), standalone operating margin compressed to 4.24% from 5.97%, and standalone NPM to 1.39% from 3.03% — consolidated profit growth this quarter is a subsidiary-and-one-off story, not a core-business one. Against our pre-result preview (consolidated revenue ₹3,200-3,400 Cr, EBITDA margin 5.5-6.0%, net profit ₹85-110 Cr), the print is mixed: revenue missed the range, operating margin beat it, and adjusted PAT (~₹106 Cr) landed near the top of the band — a scorecard closer to inline than a clean beat once the one-off is excluded. No standalone management press release accompanied this filing beyond the regulatory board-outcome letter, so there is no additional management framing to reconcile against the numbers; the quarter's other disclosed developments — the completed Medtech divestment (up to ₹40 Cr) and the dismissal of WJT's Oman arbitration claims against the company (September 15, 2026) — are already reflected in or neutral to the P&L. Management's prior tone (cautiously optimistic outlook, cautious posture per the August concall) is consistent with a quarter where the flagged margin risk in Unitary Products continued to play out rather than reverse.

29 Oct 2026, 04:15 pm

Corporate Events

Board MeetingBLUESTARCO
2026
29Oct

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing ↗
Board MeetingBLUESTARCO
2026
14Oct

Board Meeting

The Board of Directors of Blue Star International FZCO, a wh…

BSE Filing ↗
Board MeetingBLUESTARCO
2026
6Aug

Board Meeting

A meeting of the Board of Directors of the Company will be h…

BSE Filing ↗
Board MeetingBLUESTARCO
2026
6May

Board Meeting

To consider and approve the unaudited and audited financial …

BSE Filing ↗
Board MeetingBLUESTARCO
2024
6Aug

Board Meeting

Consider and approve the Un-audited Standalone and Consolida…

BSE Filing ↗
DividendBLUESTARCO
2024
19Jul

₹7 / share

BSE Filing ↗
Board MeetingBLUESTARCO
2024
2May

Board Meeting

Approval of Audited Standalone and Consolidated Financial Re…

BSE Filing ↗
Board MeetingBLUESTARCO
2024
30Jan

Board Meeting

Consider and approve Un-Audited Standalone and Consolidated …

BSE Filing ↗
Board MeetingBLUESTARCO
2023
30Oct

Board Meeting

Consider and approve Un-audited Standalone and Consolidated …

BSE Filing ↗
Board MeetingBLUESTARCO
2023
3Aug

Board Meeting

Consideration and approval of proposal for raising funds by …

BSE Filing ↗